Urokinase is a medication that is commonly used in the treatment of blood clots, specifically in the lungs (pulmonary embolism) or in the heart (coronary artery thrombosis). It works by breaking down the fibrin in blood clots, which helps to dissolve the clot and restore normal blood flow.
This medication is typically administered intravenously by a healthcare professional in a hospital setting. It is important to closely monitor patients receiving urokinase for any signs of bleeding, as this medication can increase the risk of bleeding complications.
Urokinase is a powerful clot-busting medication that can be life-saving in certain situations, such as when a patient is experiencing a heart attack or a pulmonary embolism. However, it is important to use this medication with caution and under the supervision of a healthcare provider, as it can have serious side effects.
Common side effects of urokinase may include bleeding, allergic reactions, and low blood pressure. It is important to report any unusual symptoms or side effects to your healthcare provider immediately.
Overall, urokinase is a valuable medication in the treatment of blood clots, but it should only be used under the guidance of a healthcare professional. If you have any questions or concerns about urokinase or its use, please do not hesitate to speak with your healthcare provider.
EN 
ES 
FR 
PT 
ZH